CTRI/2017/03/008078招募中2 期
A double-blind, randomized, placebo-controlled efficacy trial of individualized homeopathic treatment of geriatric depression
MBHM College Hospital MHM College Hospital The CHM College Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Aged 60-80 years, both sexes, and suffering from depression [Geriatric Depression Score: >= 5]
排除标准
- •Patients who are too sick for consultation, unwilling to take part, unable to read, and not giving consent to join the study, diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting QoL, currently receiving standard psychiatric therapy (conventional medication), chronic alcoholism, drug abuse and/or dependence, self-reported immune-compromised state, and undergoing homeopathic treatment for any chronic disease within last 6 months.
研究者
相似试验
已完成
2 期
Homeopathic treatment of bedwetting in childreCTRI/2022/04/042009D N De Homoeopathic Medical College and Hospital140
进行中（未招募）
不适用
A double-blind, placebo-controlled, randomized efficacy and safety study of levetiracetam extended release formulation (LEV XR), administered as 2 x 500 mg LEV XR tablets once daily as add-on therapy in subjects from 12 to 70 years with refractory epilepsy suffering from partial onset seizuresEUCTR2006-000987-10-FICB S.A.130
进行中（未招募）
不适用
A randomized, double-blind, placebo-controlled exploratory trial to evaluate a one-week oral treatment with R129160 (60 mg o.d.) in patients with chronic idiopathic urticaria - oral treatment with R129160 (60 mg o.d.) in patients with chronic idiopathic urticariaChronic Idiopathic UrticariaEUCTR2005-002749-38-BEBarrier Therapeutics nv48
已完成
2 期
A randomized, double-blind, placebo-controlled exploratory trial to evaluate a one-week oral treatment with R129160 (60 mg o.d.) in patients with chronic idiopathic urticariaChronic urticaria10002426NL-OMON30213Barrier Therapeutics16
进行中（未招募）
不适用
A randomized, double-blind, placebo-controlled exploratory trial to evaluate a one-week oral treatment with R129160 (60 mg o.d.) in patients with chronic idiopathic urticaria - oral treatment with R129160 (60 mg o.d.) in patients with chronic idiopathic urticariaChronic Idiopathic UrticariaEUCTR2005-002749-38-CZBarrier Therapeutics nv48